J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 90,000 shares at $60.63 ($5.4M) on 2021-10-21, disclosed to the SEC on 2021-10-25.
Open-market sale of $5.4M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.82 | 15,235 | $911K | 16.9% |
| 2 | $59.82 | 15,235 | $911K | 16.9% |
| 3 | $60.63 | 14,765 | $895K | 16.6% |
| 4 | $60.63 | 14,765 | $895K | 16.6% |
| 5 | $58.88 | 30,000 | $1.8M | 32.8% |
| Total | $59.77 avg | 90,000 |
| $5.4M |
| 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |